297 related articles for article (PubMed ID: 31809679)
1. Barriers and perceived usefulness of an ECHO intervention for office-based buprenorphine treatment for opioid use disorder in North Carolina: A qualitative study.
Shea CM; Gertner AK; Green SL
Subst Abus; 2021; 42(1):54-64. PubMed ID: 31809679
[TBL] [Abstract][Full Text] [Related]
2. Barriers and facilitators to nurse practitioner buprenorphine prescribing for opioid use disorder in primary care settings.
Speight C; Caiola C; Tyndall DE; Scott ES
J Am Assoc Nurse Pract; 2023 Feb; 35(2):112-121. PubMed ID: 36512806
[TBL] [Abstract][Full Text] [Related]
3. Association of MOUD ECHO Participation on Expansion of Buprenorphine Prescribing in Rural Primary Care.
Salvador JG; Myers OB; Bhatt SR; Jacobsohn V; Lindsey L; Alkhafaji RS; Rishel Brakey H; Sussman AL
Subst Abus; 2023 Oct; 44(4):282-291. PubMed ID: 37902036
[TBL] [Abstract][Full Text] [Related]
4. Expanding treatment for opioid use disorder in publicly funded primary care clinics: Exploratory evaluation of the NYC health + hospitals buprenorphine ECHO program.
Tofighi B; Isaacs N; Byrnes-Enoch H; Lakew R; Lee JD; Berry C; Schatz D
J Subst Abuse Treat; 2019 Nov; 106():1-3. PubMed ID: 31540604
[TBL] [Abstract][Full Text] [Related]
5. Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers.
Cochran G; Cole ES; Warwick J; Donohue JM; Gordon AJ; Gellad WF; Bear T; Kelley D; DiDomenico E; Pringle J
Addict Sci Clin Pract; 2019 Aug; 14(1):25. PubMed ID: 31366408
[TBL] [Abstract][Full Text] [Related]
6. Use of Project ECHO to promote evidence based care for justice involved adults with opioid use disorder.
Adams ZW; Agley J; Pederson CA; Bell LA; Aalsma MC; Jackson T; Grant MT; Ott CA; Hulvershorn LA
Subst Abus; 2022; 43(1):336-343. PubMed ID: 34283701
[No Abstract] [Full Text] [Related]
7. Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model.
Cloutier RM; Cole ES; McDonough BL; Lomauro DA; Miller JP; Talbert AL; Bear TM; Bridges NC; Foulds AL; Taber R; Gordon AJ; Cochran GT; Kmiec J; Donohue JM; Kelley D; DiDomenico E; Adair D; Pringle JL
Implement Res Pract; 2023; 4():26334895231152808. PubMed ID: 37091535
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and acceptability of an online ECHO intervention to expand access to medications for treatment of opioid use disorder, psychosocial treatments and supports.
Salvador JG; Bhatt SR; Jacobsohn VC; Maley LA; Alkhafaji RS; Rishel Brakey H; Myers OB; Sussman AL
Subst Abus; 2021; 42(4):610-617. PubMed ID: 32814005
[No Abstract] [Full Text] [Related]
9. Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities.
Hagedorn H; Kenny M; Gordon AJ; Ackland PE; Noorbaloochi S; Yu W; Harris AHS
Addict Sci Clin Pract; 2018 Dec; 13(1):25. PubMed ID: 30545409
[TBL] [Abstract][Full Text] [Related]
10. The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder.
Cole ES; DiDomenico E; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kim JY; Kmiec J; Kelley D; Donohue JM
J Gen Intern Med; 2019 Jun; 34(6):936-943. PubMed ID: 30887440
[TBL] [Abstract][Full Text] [Related]
11. Project ECHO and primary care buprenorphine treatment for opioid use disorder: Implementation and clinical outcomes.
Anderson JB; Martin SA; Gadomski A; Krupa N; Mullin D; Cahill A; Jenkins P
Subst Abus; 2022; 43(1):222-230. PubMed ID: 34086529
[No Abstract] [Full Text] [Related]
12. Opioid use disorder treatment and the role of New Jersey Medicaid policy changes: perspectives of office-based buprenorphine providers.
Mahone A; Enich M; Treitler P; Lloyd J; Crystal S
Am J Drug Alcohol Abuse; 2023 Sep; 49(5):606-617. PubMed ID: 37506336
[No Abstract] [Full Text] [Related]
13. The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders.
Reif S; Brolin MF; Stewart MT; Fuchs TJ; Speaker E; Mazel SB
J Subst Abuse Treat; 2020 Jan; 108():33-39. PubMed ID: 31358328
[TBL] [Abstract][Full Text] [Related]
14. Increasing North Carolina's Workforce Capacity for Prescribing Buprenorphine Products.
Cabello-De la Garza A; Harless C; Ostrach B; Fagan B
N C Med J; 2022; 83(4):288-293. PubMed ID: 35817448
[No Abstract] [Full Text] [Related]
15. Augmenting project ECHO for opioid use disorder with data-informed quality improvement.
Murray OB; Doyle M; McLeman BM; Marsch LA; Saunders EC; Cox KM; Watts D; Ryer J
Addict Sci Clin Pract; 2023 Apr; 18(1):24. PubMed ID: 37106399
[TBL] [Abstract][Full Text] [Related]
16. Use of a Benchmark Tracking Assessment to Support Expansion of Buprenorphine for Treatment of Opioid Use Disorder in Primary Care.
Sussman AL; Crawford JN; Brakey HR; Alkhafaji RS; Myers OB; Jacobsohn V; Bhatt S; Salvador J
J Am Board Fam Med; 2021; 34(6):1216-1220. PubMed ID: 34772777
[TBL] [Abstract][Full Text] [Related]
17. Nudging primary care providers to expand the opioid use disorder workforce.
Domino ME; Sylvia S; Green S
Health Serv Res; 2022 Apr; 57(2):403-410. PubMed ID: 34648182
[TBL] [Abstract][Full Text] [Related]
18. Multi-model implementation of evidence-based care in the treatment of opioid use disorder in Pennsylvania.
Kawasaki S; Francis E; Mills S; Buchberger G; Hogentogler R; Kraschnewski J
J Subst Abuse Treat; 2019 Nov; 106():58-64. PubMed ID: 31540612
[TBL] [Abstract][Full Text] [Related]
19. Association of Project ECHO Training With Buprenorphine Prescribing by Primary Care Clinicians in Minnesota for Treating Opioid Use Disorder.
Solmeyer AR; Berger AT; Barton SL; Nguyen B; Bart GB; Grahan B; Bell HJ; DeVine KM; Merrick W
JAMA Health Forum; 2022 Nov; 3(11):e224149. PubMed ID: 36399352
[TBL] [Abstract][Full Text] [Related]
20. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.
Campbell CI; Saxon AJ; Boudreau DM; Wartko PD; Bobb JF; Lee AK; Matthews AG; McCormack J; Liu DS; Addis M; Altschuler A; Samet JH; LaBelle CT; Arnsten J; Caldeiro RM; Borst DT; Stotts AL; Braciszewski JM; Szapocznik J; Bart G; Schwartz RP; McNeely J; Liebschutz JM; Tsui JI; Merrill JO; Glass JE; Lapham GT; Murphy SM; Weinstein ZM; Yarborough BJH; Bradley KA
Addict Sci Clin Pract; 2021 Jan; 16(1):9. PubMed ID: 33517894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
